The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Monkeypox Virus Test Could Yield Revenue for Its Creator

Research Report
  ()
The Utah-based diagnostics firm has multiple shots on goal with this specific molecular test and with its convenient, fast testing platform, both in development, noted an H.C. Wainwright & Co. report.

Is Reliq Health Technologies a Nutrimental 'Buy'?

Contributed Opinion
  ()
After recovering from a short "character assassination," Reliq Health Technologies may be on the up-and-up. Clive Maund examines the latest data from the company to see if it would make a good 'buy'.

Co. to Rebound After Q4/21 Sales Down Due to Virus Surge

Research Report
  ()
The 2022 outlook for a cancer detection and therapy solutions company is positive given its focus on dermatology and implementing new commercial strategies, noted an Oppenheimer report.

Biotech Could Launch Trial of Polyp Screening Test in March

Research Report
  ()
The start of the C-Scan study would be a major milestone for Check-Cap, noted an H.C. Wainwright & Co. report.

Showing Results: 1 to 9 of 9

Get Our Streetwise Reports Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe